Patterns of radiological responses to anti-PD1 in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study

被引：0

作者：

Even, C. ^{[1
]}

Bernard-Tessier, A. ^{[2
]}

Texier, M. ^{[3
]}

Said, O. Ben ^{[4
]}

Iacob, M. ^{[5
]}

Daste, A. ^{[6
]}

Fayette, J. ^{[7
]}

Zanetta, S. ^{[8
]}

Lefebvre, G. ^{[9
]}

Vinches, M. ^{[10
]}

Johnson, A. C. ^{[11
]}

Le Moal, L. Bozec ^{[12
]}

Saada, E. B. ^{[13
]}

Jallut, I. ^{[14
]}

Garic, F. ^{[15
]}

Monard, L. ^{[16
]}

Bourhis, J. ^{[17
]}

Guigay, J. ^{[18
]}

Auperin, A. ^{[19
]}

Ammari, S. ^{[20
]}

机构：

[1] Inst Gustave Roussy, Head & Neck Oncol Dept, Villejuif, France

[2] Inst Gustave Roussy, Oncol Dept, Villejuif, France

[3] Inst Gustave Roussy, Biostat & Epidemiol, Villejuif, France

[4] Gustave Roussy, Radiol, Canc Campus, Villejuif, France

[5] IRO Reg Inst Oncol, Med Oncol Dept, Villejuif, France

[6] CHU Bordeaux, Med Oncol Dept, Hop St Andre, Bordeaux, France

[7] Ctr Leon Berard, Med Oncol Dept, Lyon, France

[8] Ctr Georges Francois Leclerc Dijon, Med Oncol Dept, Dijon, France

[9] Ctr Oscar Lambret, Med Oncol Dept, Lille, France

[10] ICM Inst Canc Montpellier, Med Oncol Dept, Montpellier, France

[11] Ctr Francois Baclesse, Med Oncol Dept, Caen, France

[12] Hop Rene Huguenin, Inst Curie, Med Oncol Dept, St Cloud, France

[13] Ctr Anticancer Antoine Lacassagne, Med Oncol, Nice, France

[14] Unicancer, R&D, Paris, France

[15] Unicancer, Paris, France

[16] Unicancer, UCGI R&D, Paris, France

[17] CHU Vaudois, Radiat Oncol Dept, UNIL CHUV, Lausanne, Switzerland

[18] Ctr Anticancer Antoine Lacassagne, Med Oncol Dept, Nice, France

[19] Gustave Roussy, Biostat & Epidemiol, Canc Campus, Villejuif, France

[20] Gustave Roussy, Med Oncol Dept, Canc Campus, Villejuif, France

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.799

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

675P

引用

页码：S851 / S851

页数：1

共 50 条

[1] Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
Muratori, L.
Texier, M.
Mayache-Badis, L.
Bidault, F.
Iacob, M.
Daste, A.
Fayette, J.
Lefebvre, G.
Saada-Bouzid, E.
Zanetta, S.
Toullec, C.
Cupissol, D.
Salas, S.
Kaminsky-Forrett, M-C.
Johnson, A. C.
Ferrand, F. R.
Auperin, A.
Guigay, J.
Raynard, B.
Even, C.
ANNALS OF ONCOLOGY, 2021, 32 : S809 - S810
[2] Tumor's flare-up and patterns of recurrence in patients (pts) with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) treated with anti-PD1/PD-L1 inhibitors.
Saada-Bouzid, Esma
Defaucheux, Cecile
Karabajakian, Andy
Coloma, Virginia Palomar
Servois, Vincent
Paoletti, Xavier
Even, Caroline
Fayette, Jerome
Guigay, Joel
Loirat, Delphine
Romano, Emanuela
Le Tourneau, Christophe
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[3] Germinal immunogenetics and response to nivolumab in recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC) patients (pts): TopNIVO ancillary study
Saada, E. B.
Koudou, Y.
Daste, A.
Fayette, J.
Lefebvre, G.
Zanetta, S.
Toullec, C.
Cupissol, D.
Salas, S.
Kaminsky-Forrett, M-C.
Johnson, A. C.
Vauleon, E.
Ebran, N.
Schmidt, M.
Texier, M.
Peyrade, F.
Milano, G.
Guigay, J.
Even, C.
Etienne-Grimaldi, M-C.
ANNALS OF ONCOLOGY, 2020, 31 : S674 - S674
[4] PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the US
Hanna, Glenn J.
Zheng, Dandan
Gao, Wei
Hair, Gleicy M.
Ai, Lei
Song, Yan
Lerman, Nati
Bidadi, Behzad
Zion, Abigail
Zou, Lin
Tang, Yuexin
Wang, Liya
Merchant, Sanjay
Black, Christopher M.
ORAL ONCOLOGY, 2025, 161
[5] Phase II study of temsirolimus and erlotinib in patients (pts) with recurrent/metastatic (R/M), platinum-refractory head and neck squamous cell carcinoma (HNSCC)
Bauman, Julie E.
Arias-Pulido, Hugo
Lee, Sang-Joon
Considine, Michael
Fekrazad, M. Houman
Howard, Jason
Bishop, Justin A.
Olson, Garth T.
Jones, Dennie V.
Fertig, Elana J.
Chung, Christine H.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[6] Efficacy of cetuximab based chemotherapy after immunotherapy treatments (IT) in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts)
Hernando-Calvo, A.
Mirallas, O.
Marmolejo, D.
Felip, E.
Garralda, E.
Villacampa Javierre, G.
Feliu, B.
Martinez, S.
Gutierrez, R.
Dienstmann, R.
Brana, I.
ANNALS OF ONCOLOGY, 2019, 30 : 59 - 59
[7] Nutritional status (NS) as a strong predictor for immunotherapy (IT) outcome in recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts)
Hernando-Calvo, A.
Mirallas, O.
Marmolejo Castaneda, D. H.
Vieito, M.
Santa Gadea, O. Saavedra
Gardeazabal, I.
Villacampa Javierre, G.
Aguilar, S.
Martin Liberal, J.
Bescos, C.
Lorente, J.
Giralt, J.
Benavente, S.
Fuentes, J. F.
Temprana-Salvador, J.
Alberola, M.
Dienstmann, R.
Garralda, E.
Felip, E.
Brana, I.
ANNALS OF ONCOLOGY, 2020, 31 : S671 - S672
[8] A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Dunn, Lara
Ho, Alan Loh
Eng, Juliana
Michel, Loren S.
Fetten, James Vincent
Warner, Elizabeth
Kriplani, Anuja
Zhi, Wanqing Iris
Ng, Kenneth K.
Haque, Sofia
Pfister, David G.
Sherman, Eric Jeffrey
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[9] The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).
Scheff, Nicole N.
Nilsen, Marci Lee
Li, Jinhong
Harris, Alexandria L.
Swartz, Andrew
Hsieh, Ronan Wenhan
Anderson, Jennifer Lynn
Ferris, Robert L.
Menk, Ashley
Delgoffe, Greg M.
Zandberg, Dan Paul
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[10] Biomarkers and response to pembrolizumab (pembro) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Chow, Laura Quan Man
Mehra, Ranee
Haddad, Robert I.
Mahipal, Amit
Weiss, Jared
Berger, Raanan
Eder, Joseph Paul
Burtness, Barbara
Tahara, Makoto
Keam, Bhumsuk
Le, Dung T.
Muro, Kei
Geva, Ravit
Chung, Hyun Cheol
Lin, Chia-Chi
Ayers, Mark
Aurora-Garg, Deepti
Lunceford, Jared K.
Cheng, Jonathan D.
Seiwert, Tanguy Y.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

← 1 2 3 4 5 →